Investigating the Effect of Enzymatically-Derived Blackcurrant Extract on Skin Staphylococci Using an In Vitro Human Stratum Corneum Model
<b>Background/Objectives</b>: Numerous intrinsic and extrinsic stressors can disrupt the balance of the skin microbiome, leading to the development of various skin diseases. It has been proven that coagulase-negative staphylococci (CoNS) are important commensals for maintaining skin microbiome homeostasis and fighting cutaneous pathogens such as <i>Staphylococcus aureus</i> (<i>S. aureus</i>). Here, we examined the influence of polyphenol-rich enzymatic blackcurrant extract (EBCE) on pathogenic coagulase-positive <i>S. aureus</i> strains and beneficial CoNS, like <i>Staphylococcus epidermidis</i> (<i>S. epidermidis</i>), to explore its potential for rebalancing the skin microbiota. <b>Methods</b>: The polyphenol profile of EBCE was determined by ultra-high-pressure liquid chromatography-tandem mass spectrometry. Microwell plate assays were employed to study the effect of EBCE on five <i>S. aureus</i> strains isolated from the skin of atopic dermatitis patients. An in vitro human <i>stratum corneum</i> model was used to test its effect on mixed bacterial cultures. <b>Results</b>: EBCE inhibited the growth of all tested <i>S. aureus</i> strains by 80-100% at the highest tested concentration after 7 h. No microbial growth was observed at the highest tested EBCE concentration using the <i>stratum corneum</i> model inoculated with one selected pathogen (<i>S. aureus</i> SA-DUS-017) and one commensal laboratory strain (<i>S. epidermidis</i> DSM 20044). The lowest tested concentration did not interfere with <i>S. aureus</i> growth but strongly stimulated the growth of <i>S. epidermidis</i> (~300-fold colony forming unit increase). In addition, low EBCE concentrations strongly stimulated CoNS growth in microbiome samples taken from the armpits of healthy volunteers that were spiked with <i>S. aureus</i> SA-DUS-017. <b>Conclusions</b>: These preclinical data support further testing of EBCE-enriched topical preparations as potential cutaneous prebiotics in human studies.
Authors
- Dejan Bezbradica (ORCID: https://orcid.org/0000-0002-4385-1433)
- Patrick L.J.M. Zeeuwen (ORCID: https://orcid.org/0000-0002-6878-2438)
- Anja Petrov Ivanković (ORCID: https://orcid.org/0000-0003-4742-2297)
- Klaus Pfeffer (ORCID: https://orcid.org/0000-0002-5652-6330)
- Bernhard Homey (ORCID: https://orcid.org/0000-0002-5784-4146)
- Ana Milivojević (ORCID: https://orcid.org/0000-0002-4894-9907)
- Marija Ćorović (ORCID: https://orcid.org/0000-0001-9432-7917)
- Ellen H. van den Bogaard (ORCID: https://orcid.org/0000-0003-4846-0287)
- Patrick A.M. Jansen (ORCID: https://orcid.org/0000-0002-7894-2140)
Institutions
- Radboud University Nijmegen (NL)
- University Medical Center (US)
- Radboud University Medical Center (NL)
- University of Belgrade (RS)
- Düsseldorf University Hospital (DE)
- Heinrich Heine University Düsseldorf (DE)
Publication Details
- Journal
- Pharmaceutics
- Published
- 2025-04-08
- DOI
- https://doi.org/10.3390/pharmaceutics17040487
- Citations
- 3
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 6.01
Funders
- Science Fund of the Republic of Serbia
- HORIZON EUROPE Framework Programme